You are here: Industry Insights > EGFR

News List

Higher eGFR at Dialysis Initiation Tied to Lower Survival in Children drugs
July 22, 2019
Higher eGFR at Dialysis Initiation Tied to Lower Survival in Children.
Taiho Pharmaceutical licences lung cancer drug to Cullinan Oncology pharmaceutical-technology
February 20, 2019
Japan-based Taiho Pharmaceutical has signed an agreement to licence its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor candidate TAS6417 for lung cancer to Cullinan Oncology....
Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC worldpharmanews
September 28, 2018
Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make informed decisions on how to sequence treatments for patients with epidermal growth fact
Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer europeanpharmaceuticalreview
October 26, 2017
Researchers have proposed a unique way to reach the concentration of anti-EGFR drug needed to fight exon 20 insertions without harming healthy tissues…
AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours pharmafile
October 18, 2017
AstraZeneca and its partner and Chinese medicine (also known as Chi-Med) have announced positive data on savolitinib combined with AstraZeneca's Tagrisso or Iressa

Previous page 1 2 Next page